Genetic Evidence Supporting the Repurposing of mTOR Inhibitors for Reducing BMI
<b>Background:</b> Although mTOR has long been regarded as a promising target for cancer treatment, the efficacy of mTOR inhibitors in most clinical trials has been rather limited. Nevertheless, their favorable safety profile has opened up opportunities for drug repurposing, even as their potential...
Sábháilte in:
| Príomhchruthaitheoirí: | , , , , , , |
|---|---|
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe / Cruthaithe: |
MDPI AG
2025-03-01
|
| Sraith: | Biomedicines |
| Ábhair: | |
| Rochtain ar líne: | https://www.mdpi.com/2227-9059/13/4/839 |
| Clibeanna: |
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|